Search research articles
Contact Us
Filters
Showing results (231-240 of 318) with videos related to
Page
of 32
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 2, 2017
ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis
Theresa Bucsics, Sophie Hoffman, Johanna Grünberger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 13, 2021
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death
Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 4, 2024
Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist
Gerardo M Castillo, Yao Yao, Rebecca E Guerra, et al.
Plos Genetics
|
December 16, 2020
Culture-free genome-wide locus sequence typing (GLST) provides new perspectives on Trypanosoma cruzi dispersal and infection complexity
Philipp Schwabl, Jalil Maiguashca Sánchez, Jaime A Costales, et al.
Plos One
|
November 25, 2015
The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection
Bernhard Scheiner, Mattias Mandorfer, Philipp Schwabl, et al.
Alimentary Pharmacology & Therapeutics
|
December 3, 2016
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease
P Schwabl, M Mandorfer, S Steiner, et al.
Elife
|
August 4, 2020
Complementary α-arrestin-ubiquitin ligase complexes control nutrient transporter endocytosis in response to amino acids
Vasyl Ivashov, Johannes Zimmer, Sinead Schwabl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 3, 2020
Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease
Benedikt Simbrunner, Rodrig Marculescu, Bernhard Scheiner, et al.
Journal of Hepatology
|
February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats
Philipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Wiener Klinische Wochenschrift
|
June 20, 2018
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function
Bernhard Scheiner, Paul René Stammet, Sebastian Pokorny, et al.
Page
of 32
Search research articles
Search
Showing results (231-240 of 318) with videos related to
Sort By:
Page
of 32
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 2, 2017
ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis
Theresa Bucsics, Sophie Hoffman, Johanna Grünberger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 13, 2021
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death
Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 4, 2024
Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist
Gerardo M Castillo, Yao Yao, Rebecca E Guerra, et al.
Plos Genetics
|
December 16, 2020
Culture-free genome-wide locus sequence typing (GLST) provides new perspectives on Trypanosoma cruzi dispersal and infection complexity
Philipp Schwabl, Jalil Maiguashca Sánchez, Jaime A Costales, et al.
Plos One
|
November 25, 2015
The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection
Bernhard Scheiner, Mattias Mandorfer, Philipp Schwabl, et al.
Alimentary Pharmacology & Therapeutics
|
December 3, 2016
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease
P Schwabl, M Mandorfer, S Steiner, et al.
Elife
|
August 4, 2020
Complementary α-arrestin-ubiquitin ligase complexes control nutrient transporter endocytosis in response to amino acids
Vasyl Ivashov, Johannes Zimmer, Sinead Schwabl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 3, 2020
Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease
Benedikt Simbrunner, Rodrig Marculescu, Bernhard Scheiner, et al.
Journal of Hepatology
|
February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats
Philipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Wiener Klinische Wochenschrift
|
June 20, 2018
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function
Bernhard Scheiner, Paul René Stammet, Sebastian Pokorny, et al.
Page
of 32